Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May;53(5):1863-7.
doi: 10.1128/AAC.01149-08. Epub 2009 Feb 17.

Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients

Federico Pea  1 , Mario Furlanut, Camilla Negri, Federica Pavan, Massimo Crapis, Francesco Cristini, Pierluigi Viale
Affiliations

Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients

Federico Pea et al. Antimicrob Agents Chemother. 2009 May.

Abstract

The efficacy of vancomycin against methicillin-resistant Staphylococcus aureus (MRSA)-related infections has been called into question by recent findings of higher rates of failure of vancomycin treatment of infections caused by strains with high MICs. Continuous infusion may be the best way to maximize the time-dependent activity of vancomycin. The aim of this study was to create dosing nomograms in relation to different creatinine clearance (CL(Cr)) estimates for use in daily clinical practice to target the steady-state concentrations (C(ss)s) of vancomycin during continuous infusion at 15 to 20 mg/liter (after the administration of an initial loading dose of 15 mg/kg of body weight over 2 h). The correlation between vancomycin clearance (CL(v)) and CL(Cr) was retrospectively assessed in a cohort of critically ill patients (group 1, n = 70) to create a formula for dosage calculation to target C(ss) at 15 mg/liter. The performance of this formula was prospectively validated in a similar cohort (group 2, n = 63) by comparison of the observed and the predicted C(ss)s. A significant relationship between CL(v) and CL(Cr) was observed in group 1 (P < 0.001). The application of the calculated formula to vancomycin dosing in group 2 {infusion rate (g/24 h) = [0.029 x CL(Cr) (ml/min) + 0.94] x target C(ss) x (24/1,000)} led to a significant correlation between the observed and the predicted C(ss)s (r = 0.80, P < 0.001). Two dosing nomograms based on CL(Cr) were created to target the vancomycin C(ss) at 15 and 20 mg/liter in critically ill patients. These nomograms could be helpful in improving the vancomycin treatment of MRSA infections, especially in the presence of borderline-susceptible pathogens and/or of pathophysiological conditions which may enhance the clearance of vancomycin, while potentially avoiding the increased risk of nephrotoxicity observed with the use of high intermittent doses of vancomycin.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Relationship between individual CLv and CLCr estimated by means of the formula of Cockcroft and Gault (3) in group 1 (n = 70 patients and 151 samples): CLv (liters/h) = 0.029 × CLCr (ml/min) + 0.94 (r = 0.75, P < 0.001).
FIG. 2.
FIG. 2.
Relationship between the predicted and the observed vancomycin Csss in group 2 (n = 63 patients and 120 samples). (r = 0.80, P < 0.001).
FIG. 3.
FIG. 3.
Nomogram based on CLCr estimates (3) for calculation of the vancomycin daily dosage administered by continuous infusion which is needed for achievement of the target Css of 15 mg/liter in critically ill patients.
FIG. 4.
FIG. 4.
Nomogram based on CLCr estimates (3) for calculation of the vancomycin daily dosage administered by continuous infusion which is needed for achievement of the target Css of 20 mg/liter in critically ill patients.
See this image and copyright information in PMC

References

    1. Alos, J. I., A. Garcia-Canas, P. Garcia-Hierro, and F. Rodriguez-Salvanes. 2008. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage. J. Antimicrob. Chemother. 62:773-775. - PubMed
    1. American Thoracic Society and Infectious Diseases Society of America. 2005. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171:388-416. - PubMed
    1. Cockcroft, D. W., and M. H. Gault. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41. - PubMed
    1. Dellinger, R. P., M. M. Levy, J. M. Carlet, J. Bion, M. M. Parker, R. Jaeschke, K. Reinhart, D. C. Angus, C. Brun-Buisson, R. Beale, T. Calandra, J. F. Dhainaut, H. Gerlach, M. Harvey, J. J. Marini, J. Marshall, M. Ranieri, G. Ramsay, J. Sevransky, B. T. Thompson, S. Townsend, J. S. Vender, J. L. Zimmerman, and J. L. Vincent. 2008. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 34:17-60. - PMC - PubMed
    1. Deresinski, S. 2007. Counterpoint: vancomycin and Staphylococcus aureus—an antibiotic enters obsolescence. Clin. Infect. Dis. 44:1543-1548. - PubMed

MeSH terms